Cardio Diagnostics Holdings Launches Revolutionary Blood Test

VIP LIVEALERTS-PRO Cardio Diagnostics Holdings Inc Cardio Diagnostics Holdings Inc Launches Revolutionary Blood Test for Early Detection of Coronary Heart Disease PrecisionCHD™ is the First Integrated Epigenetic-Genetic-Based Blood Test for the Early Detection of Coronary Heart Disease February 28, 2023 08:00 AM Eastern Standard Time CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics Holdings Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular […]